ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 17 filers reported holding ARRAY BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $34,266,000 | +33.6% | 19,000,000 | 0.0% | 1.69% | +8.2% |
| Q2 2017 | $25,656,000 | +101.0% | 19,000,000 | +111.1% | 1.56% | +88.6% |
| Q1 2017 | $12,763,000 | +1.3% | 9,000,000 | 0.0% | 0.83% | -23.8% |
| Q4 2016 | $12,593,000 | +164.5% | 9,000,000 | +125.0% | 1.09% | +186.5% |
| Q3 2016 | $4,761,000 | +40.8% | 4,000,000 | 0.0% | 0.38% | +17.3% |
| Q2 2016 | $3,382,000 | +5.0% | 4,000,000 | 0.0% | 0.32% | -2.1% |
| Q1 2016 | $3,220,000 | -13.0% | 4,000,000 | 0.0% | 0.33% | +19.1% |
| Q4 2015 | $3,702,000 | -6.1% | 4,000,000 | 0.0% | 0.28% | -7.4% |
| Q3 2015 | $3,942,000 | -21.9% | 4,000,000 | 0.0% | 0.30% | -27.8% |
| Q2 2015 | $5,050,000 | +0.6% | 4,000,000 | 0.0% | 0.41% | -8.2% |
| Q1 2015 | $5,022,000 | +168.7% | 4,000,000 | +100.0% | 0.45% | +122.2% |
| Q4 2014 | $1,869,000 | -45.7% | 2,000,000 | -33.3% | 0.20% | -60.9% |
| Q3 2013 | $3,444,000 | +20.5% | 3,000,000 | 0.0% | 0.52% | +3.0% |
| Q2 2013 | $2,859,000 | – | 3,000,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|